New FDA Review Process Debated

Industry experts discuss the agency’s plans to make the drug approval process more transparent.

By | June 20, 2012

image: New FDA Review Process Debated Dreamstime, Vichaya Kiatying-angsulee

DREAMSTIME, VICHAYA KIATYING-ANGSULEE

A new plan by the US Food and Drug Administration (FDA) to make the review process for new drugs more open and streamlined drew criticism by industry experts attending the annual Biotechnology Industry Organization’s convention, held in Boston this week.

Known as the “benefit-risk framework,” the agency’s proposal aims to improve the review criteria for new drugs by making the process more accessible to companies and the general public and less of a “black box,” as some in the industry have described it, The Boston Globe reported. It would also provide the first-ever formal and structured framework for reviewing drugs.

But the proposal is not without its share of skeptics. After attending one of the FDA panels at the conference, Vladimir Shnaydman, president of the life science consulting firm, Orbee Consulting, described the agency’s actions as “Kindergarten.” “They move too slowly, and this is very disappointing,” he told The Globe.

There has also been a debate about making the drug approval process more quantitative and reliant on data, with experts voicing the pros and cons of such a move. “Quantification can be useful in drug development to help structure go or no-go decisions,” Rebecca Noel, senior research scientist at Eli Lilly & Co., told The Globe. “But I don’t think any of us have reached the stage where we think quantification can make the decision on a regulatory review. It can help inform the decision, but not make the decision.”

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. Antibiotic Resistance Can Boost Bacterial Fitness
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Advertisement
The Scientist